A detailed history of Jpmorgan Chase & CO transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 26 shares of ARMP stock, worth $54. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 27 3.7%
Holding current value
$54
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$2.1 - $3.3 $2 - $3
-1 Reduced 3.7%
26 $0
Q2 2024

Aug 12, 2024

BUY
$2.4 - $3.9 $2 - $3
1 Added 3.85%
27 $0
Q1 2024

May 10, 2024

SELL
$2.81 - $4.18 $221 - $330
-79 Reduced 75.24%
26 $0
Q4 2023

Feb 12, 2024

BUY
$1.95 - $3.24 $204 - $340
105 New
105 $0
Q2 2023

Aug 11, 2023

BUY
$1.14 - $1.7 $168 - $251
148 New
148 $0

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $75.9M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.